ClinicalTrials.Veeva

Menu

Prospective Evaluation of Adventitial Histopathology in Borderline Ascending Aortic Dilatatio

S

Samsun University

Status

Active, not recruiting

Conditions

Coronary Artery Bypass Grafting (CABG)
Borderline Aortic Dilatation
Ascending Aortic Aneurysm
Aortic Adventitial Pathology

Study type

Observational

Funder types

Other

Identifiers

NCT07034586
SUKAEK-2023 1/19

Details and patient eligibility

About

This prospective study investigates microscopic changes in the outer layer (adventitia) of the ascending aorta in patients undergoing coronary artery bypass grafting (CABG) surgery. The study includes two groups of patients: (1) those with borderline ascending aortic dilatation (4.0-5.0 cm), and (2) a control group with normal aortic diameter (<4.0 cm), all undergoing the same surgical procedure. During CABG, a small circular punch is routinely made in the ascending aorta for the proximal saphenous vein graft anastomosis. The tissue removed from this punch site is collected and used for histopathological and immunohistochemical analysis. The study aims to determine whether adventitial changes correlate with aortic size and whether these changes can help identify patients at risk for future aortic dissection or rupture. The findings may guide surgical decision-making in patients with borderline aortic enlargement.

Enrollment

102 patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adults aged between 20 and 70 years

  2. Patients scheduled for elective open-heart coronary artery bypass grafting (CABG)

  3. Patients undergoing their first cardiac surgery

  4. Metabolically stable patients

  5. Aortic diameter:

    1. Observational aortic dilatation group: between 4.0 cm and 5.0 cm
    2. Control group: less than 4.0 cm
  6. Written informed consent obtained from the patient

Exclusion criteria

  1. History of previous cardiac surgery
  2. History of aortic dissection or rupture
  3. Known genetic syndromes (e.g., Marfan, Loeys-Dietz, Ehlers-Danlos)
  4. Known systemic vasculitis
  5. Presence of acute infection or systemic inflammatory disease
  6. Inadequate biopsy material for pathological analysis
  7. Patients not undergoing any aortic intervention during surgery

Trial design

102 participants in 2 patient groups

Observational Aort Dilated Group
Description:
Patients undergoing elective coronary artery bypass grafting (CABG) with an ascending aortic diameter between 4.0 cm and 5.0 cm. These patients do not have known genetic aortopathy and are undergoing their first cardiac surgery. Aortic tissue samples are collected during surgery from the punch biopsy site used for proximal anastomosis.
Observational Control Group
Description:
Patients undergoing elective CABG with an ascending aortic diameter less than 4.0 cm. These patients also do not have known aortopathies and are undergoing their first cardiac surgery. Punch biopsy material is similarly collected for histopathological evaluation.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems